Published in Cell on September 09, 2011
Natural products: a continuing source of novel drug leads. Biochim Biophys Acta (2013) 4.12
Platforms for antibiotic discovery. Nat Rev Drug Discov (2013) 3.66
The quest for modernisation of traditional Chinese medicine. BMC Complement Altern Med (2013) 1.24
Network-based drug discovery by integrating systems biology and computational technologies. Brief Bioinform (2012) 1.09
Drug resistance genomics of the antimalarial drug artemisinin. Genome Biol (2014) 0.95
Dihydroartemisinin exerts its anticancer activity through depleting cellular iron via transferrin receptor-1. PLoS One (2012) 0.93
Distinctive origin of artemisinin-resistant Plasmodium falciparum on the China-Myanmar border. Sci Rep (2016) 0.92
pH-responsive artemisinin derivatives and lipid nanoparticle formulations inhibit growth of breast cancer cells in vitro and induce down-regulation of HER family members. PLoS One (2013) 0.86
Synthesis and antimalarial efficacy of two-carbon-linked, artemisinin-derived trioxane dimers in combination with known antimalarial drugs. J Med Chem (2013) 0.85
Artemisinin-based antimalarial research: application of biotechnology to the production of artemisinin, its mode of action, and the mechanism of resistance of Plasmodium parasites. J Nat Med (2016) 0.81
Identification of plumbagin and sanguinarine as effective chemotherapeutic agents for treatment of schistosomiasis. Int J Parasitol Drugs Drug Resist (2013) 0.81
Acid-mediated coupling of γ-hydroxybutenolides and aldehydes: Synthesis of a new class of spirocyclic ketal-lactones. Tetrahedron Lett (2012) 0.79
Potent in vitro antiviral activity of Cistus incanus extract against HIV and Filoviruses targets viral envelope proteins. Sci Rep (2016) 0.79
Artemisinin-derived dimer phosphate esters as potent anti-cytomegalovirus (anti-CMV) and anti-cancer agents: a structure-activity study. Bioorg Med Chem (2013) 0.78
Antimalarials inhibit hematin crystallization by unique drug-surface site interactions. Proc Natl Acad Sci U S A (2017) 0.78
Discovery and development of natural product oridonin-inspired anticancer agents. Eur J Med Chem (2016) 0.77
Structural Studies of Geosmin Synthase, a Bifunctional Sesquiterpene Synthase with αα Domain Architecture That Catalyzes a Unique Cyclization-Fragmentation Reaction Sequence. Biochemistry (2015) 0.76
Overexpression of AaWRKY1 Leads to an Enhanced Content of Artemisinin in Artemisia annua. Biomed Res Int (2016) 0.76
Artemisinin: the gifts from traditional Chinese medicine not only for malaria control but also for schistosomiasis control. Parasitol Res (2011) 0.76
Recent advances in biosynthesis of bioactive compounds in traditional Chinese medicinal plants. Sci Bull (Beijing) (2015) 0.76
Si-Accumulation In Artemisia annua Glandular Trichomes Increases Artemisinin Concentration, but Does Not Interfere In the Impairment of Toxoplasma gondii Growth. Front Plant Sci (2016) 0.76
Antimalarial chemotherapy: artemisinin-derived dimer carbonates and thiocarbonates. Bioorg Med Chem Lett (2014) 0.76
Domestic trends in malaria research and development in China and its global influence. Infect Dis Poverty (2017) 0.75
Synthesis of medicinally relevant terpenes: reducing the cost and time of drug discovery. Future Med Chem (2014) 0.75
Artemisinin and its derivatives in treating protozoan infections beyond malaria. Pharmacol Res (2016) 0.75
Antimalarial chemotherapy: orally curative artemisinin-derived trioxane dimer esters. Bioorg Med Chem Lett (2014) 0.75
Antidiabetic potential of some less commonly used plants in traditional medicinal systems of India and Nigeria. J Intercult Ethnopharmacol (2014) 0.75
A Systematic Review of Anti-malarial Properties, Immunosuppressive Properties, Anti-inflammatory Properties, and Anti-cancer Properties of Artemisia Annua. Electron Physician (2016) 0.75
pH-responsive artemisinin dimer in lipid nanoparticles are effective against human breast cancer in a xenograft model. J Pharm Sci (2015) 0.75
Identification of natural products with neuronal and metabolic benefits through autophagy induction. Autophagy (2016) 0.75
Three-dimensional structures in the design of therapeutics targeting parasitic protozoa: reflections on the past, present and future. Acta Crystallogr F Struct Biol Commun (2015) 0.75
The conifer biomarkers dehydroabietic and abietic acids are widespread in Cyanobacteria. Sci Rep (2016) 0.75
Preclinical Efficacy and Safety Assessment of Artemisinin-Chemotherapeutic Agent Conjugates for Ovarian Cancer. EBioMedicine (2016) 0.75
Diabetic Nephropathy: Proteinuria, Inflammation, and Fibrosis. J Diabetes Res (2016) 0.75
Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs. Oncotarget (2016) 0.75
The Effects of Artemisinin on the Cytolytic Activity of Natural Killer (NK) Cells. Int J Mol Sci (2017) 0.75
A review of dihydroartemisinin as another gift from traditional Chinese medicine not only for malaria control but also for schistosomiasis control. Parasitol Res (2014) 0.75
Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med (2009) 33.25
Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature (2002) 12.09
Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell (2000) 10.72
Pyrethroid resistance in African anopheline mosquitoes: what are the implications for malaria control? Trends Parasitol (2010) 8.80
Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bednets and artemisinin-based combination therapies: a longitudinal study. Lancet Infect Dis (2011) 7.42
Changes in the burden of malaria in sub-Saharan Africa. Lancet Infect Dis (2010) 7.42
Mefloquine (WR 142,490) in the treatment of human malaria. Science (1975) 5.20
Qinghaosu (artemisinin): an antimalarial drug from China. Science (1985) 4.95
Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria. Proc Natl Acad Sci U S A (2011) 3.23
Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion. Proc Natl Acad Sci U S A (2011) 2.94
Antimalarial activity of mefloquine and qinghaosu. Lancet (1982) 1.81
Randomised comparative study of mefloquine, qinghaosu, and pyrimethamine-sulfadoxine in patients with falciparum malaria. Lancet (1984) 1.42
Antimalaria studies on Qinghaosu. Chin Med J (Engl) (1979) 1.38
Decreased prevalence of the Plasmodium falciparum chloroquine resistance transporter 76T marker associated with cessation of chloroquine use against P. falciparum malaria in Hainan, People's Republic of China. Am J Trop Med Hyg (2005) 2.02
Mutations in transmembrane domains 1, 4 and 9 of the Plasmodium falciparum chloroquine resistance transporter alter susceptibility to chloroquine, quinine and quinidine. Mol Microbiol (2006) 1.51
Gene structure and expression of a Plasmodium falciparum 220-kDa protein homologous to the Plasmodium vivax reticulocyte binding proteins. Mol Biochem Parasitol (2002) 1.38
In vitro sensitivity of Plasmodium falciparum clinical isolates from the China-Myanmar border area to quinine and association with polymorphism in the Na+/H+ exchanger. Antimicrob Agents Chemother (2010) 1.34
Identification of a subtelomeric gene family expressed during the asexual-sexual stage transition in Plasmodium falciparum. Mol Biochem Parasitol (2005) 1.24
Angiogenesis inhibitors specific for methionine aminopeptidase 2 as drugs for malaria and leishmaniasis. J Biomed Sci (2002) 1.09
Molecular and epidemiological characterization of Plasmodium vivax recurrent infections in southern Mexico. Parasit Vectors (2013) 1.00
Malaria: therapy, genes and vaccines. Curr Mol Med (2006) 0.93
Genetic diversity and population history of Plasmodium falciparum and Plasmodium vivax. Parassitologia (2006) 0.85
The Multilateral Initiative on Malaria: looking back and looking ahead. Trends Parasitol (2010) 0.79